Pharmacovigilance Experts are key players in the pharmaceutical industry, tasked with ensuring the ongoing safety and effectiveness of medicines. Their main role involves collecting, analyzing, and interpreting data related to adverse drug reactions (ADRs), helping to identify new risks or confirm known ones. These experts monitor both clinical trial data and post-marketing reports to detect safety signals early and prevent harm to patients. They prepare detailed safety reports, manage regulatory submissions, and maintain compliance with international pharmacovigilance regulations such as those from the FDA, EMA, and ICH.
These professionals possess strong analytical, communication, and decision-making skills, which are essential for assessing complex safety data and making informed recommendations. They work closely with regulatory teams, medical affairs, and research and development departments to ensure all safety concerns are addressed appropriately. With the growing volume of real-world data and digital health records, their role is evolving to include advanced data analytics and AI tools. As new therapies—especially biologics and personalized medicines—enter the market, their role becomes even more critical. Pharmacovigilance experts help guide decisions that can lead to label updates, safety warnings, or even product withdrawal when needed. By identifying patterns in adverse event reports and applying medical judgment, they help reduce risks and ensure that the benefits of a drug continue to outweigh its risks. Their work protects both patients and public health on a global scale.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India